Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2019 | LncRNA expression in IgM MGUS: a potential malignant driver for WM?

Stephen Ansell • 7 Dec 2019
ASH 2019
B-Cell Lymphoma Indolent B-Cell Lymphoma Non-Hodgkin Lymphoma Rare Diseases Waldenström’s Macroglobulinemia

Waldenström’s macroglobulinemia (WM) is preceded by an IgM monoclonal gammopathy of undetermined significance (MGUS), and our understanding of the underlying pathobiology of these conditions is still evolving. Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN, discusses the long non-coding (lnc)RNA expression profile in patients with WM and MGUS. Several known oncogenes were found to be in proximity of overexpressed lncRNAs in WM compared to IgM MGUS, which suggests that this could be a potential mechanism driving the transformation of IgM MGUS to WM.

More from Stephen Ansell

MBL: biology, classification & the possibility of early interception
Andrew Rawstron et al. • 25 Mar 2024
1:03
What’s on the horizon for Hodgkin lymphoma?
Stephen Ansell • 11 Dec 2023
0:51
Treating patients with Hodgkin lymphoma who are chemo-resistant
Stephen Ansell • 11 Dec 2023
1:21
Hodgkin lymphoma highlights from ASH 2023: nivo-AVD versus BV-AVD in patients with HL
Stephen Ansell • 11 Dec 2023

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals